Literature DB >> 8386330

Alpha 2- and beta-adrenergic stimulation of corticosterone secretion in rats.

W M Daniels1, A Jaffer, V A Russell, J J Taljaard.   

Abstract

Bilateral injection of 6-hydroxydopamine into the medial forebrain bundle (MFB) significantly decreased monoamine concentrations in the hypothalamus. The noradrenaline and serotonin content of the paraventricular nucleus (PVN) was also significantly reduced. These drastic decreases in neurotransmitter concentration did not alter basal secretion of corticosterone. Isoproterenol, a beta-adrenoceptor agonist (1 mg/kg, i.p.), significantly stimulated corticosterone release in saline and MFB lesioned rats. This stimulation did not differ significantly between the two groups. Clonidine, an alpha 2-adrenoceptor agonist, injected either intraperitoneally or intracerebrally just dorsal to the PVN, caused a dose-dependent increase in corticosterone secretion. The stimulation of corticosterone release by clonidine (250 micrograms/kg, i.p.) was antagonised by the selective alpha 2-adrenoceptor antagonist, yohimbine (1 mg/kg, i.p.) and significantly reduced by the MFB lesion. These results suggest that corticosterone secretion is stimulated by activation of alpha 2-adrenoceptors which occur on noradrenergic nerve terminals in the PVN.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386330     DOI: 10.1007/bf01474679

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  41 in total

Review 1.  Adrenergic mechanisms in the control of corticotrophin secretion.

Authors:  S al-Damluji
Journal:  J Endocrinol       Date:  1988-10       Impact factor: 4.286

2.  CRF-containing neurons of the rat hypothalamus.

Authors:  S Daikoku; Y Okamura; H Kawano; Y Tsuruo; M Maegawa; T Shibasaki
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

3.  Norepinephrine in the paraventricular nucleus stimulates corticosterone release.

Authors:  S F Leibowitz; S Diaz; D Tempel
Journal:  Brain Res       Date:  1989-09-04       Impact factor: 3.252

Review 4.  Overview: toward a dysregulation hypothesis of depression.

Authors:  L J Siever; K L Davis
Journal:  Am J Psychiatry       Date:  1985-09       Impact factor: 18.112

5.  Inhibitory effect of norepinephrine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.

Authors:  T Suda; F Yajima; N Tomori; T Sumitomo; Y Nakagami; T Ushiyama; H Demura; K Shizume
Journal:  Life Sci       Date:  1987-04-27       Impact factor: 5.037

6.  Distribution of corticotropin-releasing factor in rat brain.

Authors:  M Palkovits; M J Brownstein; W Vale
Journal:  Fed Proc       Date:  1985-01

7.  The effect of partial noradrenergic denervation on corticosterone secretion in the rat.

Authors:  W M Daniels; A Jaffer; A Searson; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1989-12       Impact factor: 3.996

8.  Adrenergic mechanisms involved in the control of pituitary-adrenal activity in the rat: a beta-adrenergic stimulatory mechanism.

Authors:  F J Tilders; F Berkenbosch; P G Smelik
Journal:  Endocrinology       Date:  1982-01       Impact factor: 4.736

9.  Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in primary unipolar major depressive disorder.

Authors:  A S de Villiers; V A Russell; M E Carstens; C Aalbers; C A Gagiano; D O Chalton; J J Taljaard
Journal:  Psychiatry Res       Date:  1987-10       Impact factor: 3.222

10.  Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.

Authors:  S Tsagarakis; J M Holly; L H Rees; G M Besser; A Grossman
Journal:  Endocrinology       Date:  1988-10       Impact factor: 4.736

View more
  1 in total

1.  Systemic administration of leptin decreases plasma corticosterone levels: role of hypothalamic norepinephrine.

Authors:  Kimberly A Clark; Andew C Shin; Madhu P Sirivelu; Sheba M J Mohankumar; P S Mohankumar
Journal:  Brain Res       Date:  2007-12-14       Impact factor: 3.252

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.